Most commonly, preventative surgical resection is performed for patients with gene mutations in BRCA1, BRCA2, PTEN, and p53 for patients with family histories of breast cancer, and is not typically recommended to persons with an average risk of breast cancer [7]. This evidence concerns the gene BRCA1 and breast carcinoma.